Pharmaceutical Continuous Manufacturing Market Outlook 2025 – Insights for Executive and Strategic Planning
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Pharmaceutical Continuous Manufacturing Market Grown from 2024 to 2025?
The market size of pharmaceutical continuous manufacturing has seen a swift growth in the past few years. Beginning at a value of $2.47 billion in 2024, the market is projected to escalate to $2.72 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 10.2%. Factors such as enhancements in quality and efficiency, diminished time-to-market, cost curtailment and operational efficiency, along with regulatory backing and directives, as well as flexibility and scalability have largely contributed to growth during the historical period.
What Growth Rate Is Anticipated for the Pharmaceutical Continuous Manufacturing Market in the Coming Years?
The market size for continuous manufacturing in pharmaceuticals is predicted to experience a quick expansion in the upcoming years, with projections stating it will reach $4.15 billion by 2029, following a compound annual growth rate (CAGR) of 11.2%. The predicted growth during this forecast period is mainly due to an increase in the production of generic drugs, biopharmaceutical manufacturing, as well as personalized medicine manufacturing, and a focus on patient-centered approaches. Key trends to observe during this forecast period include the adoption of continuous manufacturing, the integration of process analytical technology, the application of advanced automation and robotics, strategic collaborations and partnerships, and the trend of digitalization and connectivity.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12123&type=smp
Who Are the Leading Companies in the Pharmaceutical Continuous Manufacturing Market?
Major companies operating in the pharmaceutical continuous manufacturing market include Pfizer Inc., Robert Bosch GmbH, Siemens AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline Plc., Eli Lilly and Company, Corning Inc., Vertex Pharmaceuticals, Lonza Group Ltd., GEA Group AG, Catalent Inc., Mettler Toledo, Patheon, Cytiva, Samsung Biologics Co.Ltd., WuXi Biologics, Syntegon Technology GmbH, Coperion GmbH, Hosokawa Micron Group, FUJIFILM Diosynth Biotechnologies, Leistritz AG, Glatt GmbH, Freund-Vector Corp., SK biotek Co. Ltd., Gericke AG, GEBRÜDER LÖDIGE MASCHINENBAU GmbH, Munson Machinery Company Inc., L.B. Bohle Maschinen und Verfahren GmbH, KORSCH AG, Chemtrix BV
What Are the Key Drivers of the Pharmaceutical Continuous Manufacturing Market?
The increasing instances of numerous long-term illnesses are predicted to fuel the advancement of the continuous manufacturing market in the pharmaceutical industry. Chronic illnesses, which last a year or more, necessitate ongoing medical care and disrupt daily tasks, are collectively termed as such. The pharmaceutical sector benefits from continuous manufacturing operations by improving the production of medications, enhancing efficiency and reducing expenses. It also facilitates greater availability of vital medications, crucial for managing enduring ailments that demand lengthy periods of medicinal treatment. For example, a report produced by the National Association of Chronic Disease Directors (NACDD), a non-profit Public Health organization in the US dedicated to programs related to chronic diseases, stated in April 2022 that nearly 60% of adult Americans are afflicted by at least one chronic disease, and around 40% have more than one chronic conditions (MCC). This is projected to burden the US economy with an annual cost of $2 trillion or $8,600 per individual by 2030. Consequently, the rising incidents of various persisting diseases will boost the continuous manufacturing sector in the pharmaceutical industry.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12123&type=smp
What Are the Key Market Segments in the Pharmaceutical Continuous Manufacturing Industry?
The pharmaceutical continuous manufacturing market covered in this report is segmented –
1) By Product: Integrated Continuous System, Control And Software, Semi-Continuous System
2) By Therapeutics Type: Large Molecule, Small Molecule
3) By Formulation: Solid Formation, Liquid And Semi-Solid Formation
4) By Application: Final Drug Product Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing
5) By End-Users: Pharmaceutical Companies, Contract Manufacturing Organization, Other End-Users
Subsegments:
1) By Integrated Continuous System: Continuous Mixer Systems, Continuous Granulation Systems, Continuous Tablet Press Systems, Continuous Coating Systems
2) By Control and Software: Process Analytical Technology (PAT) Tools, Manufacturing Execution Systems (MES), Control Software for Automation, Data Management and Visualization Software
3) By Semi-Continuous System: Batch-to-Continuous Transition Systems, Hybrid Systems, Semi-Continuous Granulation and Drying Systems
What Are the Latest Trends in the Pharmaceutical Continuous Manufacturing Market?
Technological advancements are emerging as a significant trend within the pharmaceutical continuous manufacturing market. Major firms within this industry are introducing new products to maintain market dominance. For instance, in December 2022, the United States Pharmacopeia (USP), a not-for-profit organization based in the US that holds both the copyright and the trademark for the Pharmacopeia National Formulary (USP-NF), inaugurated the USP Advanced Manufacturing Technology Lab. This was accompanied by the launch of R&D analytical solutions. These analytical lab services promise to facilitate drug makers in incorporating advanced manufacturing technologies, like pharmaceutical continuous manufacturing (PCM). This will promote geographic diversity in pharmaceutical manufacturing and enhance the resilience of the medicine supply chain. It will also encompass the description of materials as well as the creation and qualification of methods to support and guarantee the quality of PCM-related drugs.
Access The Full Report Here:
What Are the Key Regional Markets in the Pharmaceutical Continuous Manufacturing Industry?
Western Europe was the largest region in the pharmaceutical continuous manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical continuous manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12123
This Report Delivers Insight On:
1. How big is the pharmaceutical continuous manufacturing market, and how is it changing globally?
2. Who are the major companies in the pharmaceutical continuous manufacturing market, and how are they performing?
3. What are the key opportunities and risks in the pharmaceutical continuous manufacturing market right now?
4. Which products or customer segments are growing the most in the pharmaceutical continuous manufacturing market?
5. What factors are helping or slowing down the growth of the pharmaceutical continuous manufacturing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
